Tue.Mar 09, 2021

article thumbnail

Why hasn’t pharma embraced email marketing?

World of DTC Marketing

SUMMARY : DTC marketers are spending tens of millions of dollars on programmatic ads that are full of fraud and have low click-through rates but they have yet to embrace email marketing which has an average click-through rate of 3.43%. There is no doubt that more people are using the Internet for online health searches, but the downside is that there is a lot of bad/false health information online. eMail represents an opportunity for pharmaceutical companies to get closer to their customers w

Marketing 289
article thumbnail

Taking a page from Celgene, Takeda builds and buys a cancer biotech

Bio Pharma Dive

An agreement to acquire Maverick Therapeutics for up to $525 million has roots in a plan hatched by Takeda to emulate elements of Celgene's dealmaking strategy.

291
291
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In the News: February 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. FDA: Sponsors Seldom Disclose RTF Letters’ Existence or Contents and Often Ignore Agency Advice. The FDA revealed that pharma companies are not forthcoming when they publicly disclose the reasons behind a refuse-to-file (RTF) letter from the Agency.

article thumbnail

Acadia shares plunge after unexpected FDA feedback

Bio Pharma Dive

According to Acadia, the FDA had said multiple times that there were no problems with its drug approval application. But last week, the agency surprisingly reversed course.

Drugs 161
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Syngenta and Botanical Solution Inc. (BSI) team up for a new botanical-based biofungicde rollout !

Pharma Mirror

Davis, CA: Botanical Solution Inc. (BSI) and Syngenta, two companies which are closely aligned in their commitment to innovation and sustainability in agriculture, announce that they have reached an agreement to commercialize BSI’s first product in Peru and Mexico. The two companies have already commercialized successfully the product in Chile under the trade name BotristopÒ.

article thumbnail

Novartis bid to bring rare disease drug to lung cancer hits a roadblock

Bio Pharma Dive

Promising signs from a cardiovascular trial had led the Swiss firm to test canakinumab, a drug for rare immune diseases, in lung cancer. But the first test of that theory has failed.

Drugs 141

More Trending

article thumbnail

Why pharma isn’t yet achieving digital excellence, and how it can get there

pharmaphorum

Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods. To thrive in this environment, pharma needs to move from ad-hoc and reactionary digital transformation to long-term ‘digital excellence’, says Veeva’s Sebastien Noel. COVID has seen pharma sales experience three years’ worth of digital transformation in the space of just a few months – but while the industry has embraced digital tools and techniques, most companies are still far from

Sales 131
article thumbnail

Pfizer COVID-19 vaccine appears effective against Brazil variant

BioPharma Reporter

A laboratory study published in the New England Journal of Medicine shows the Pfizer/BioNTech COVID-19 vaccine was able to neutralize the emerging Brazil coronavirus strain.

article thumbnail

COVID cough app Hyfe launches in UK and Ireland

pharmaphorum

A smartphone app that uses artificial intelligence to assess the sound of coughing has been launched in the UK, and according to its developer could be an early warning system for COVID-19 and other diseases of the lung. . Hyfe uses acoustic technology to track users’ coughing habits, gauging factors like volume, frequency, amplitude and context, whilst running in the background on an iOS or Android device.

article thumbnail

Lilly’s Antibody Combo Reduces Death, Hospitalization in Early COVID-19

BioSpace

Bamlanivimab is a product born from a collaboration between Lilly and AbCellera, with Lilly reportedly developing the therapy in under three months following discovery by AbCellera.

Antibody 102
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Roche’s Tecentriq loses bladder cancer use as FDA crackdown continues

pharmaphorum

Roche’s Tecentriq is the latest medicine to fall foul of a crackdown by the FDA on drugs that have failed to live up to their early promise. The Swiss pharma said it is voluntarily withdrawing the US indication for the immunotherapy Tecentriq (atezolizumab) in metastatic urothelial carcinoma (mUC) previously treated with chemotherapy. As with AstraZeneca’s Imfinzi in previously treated bladder cancer, Merck & Co’s Keytruda in previously treated metastatic small cell lung cancer , and B

article thumbnail

Researchers develop roadside barrier design to mitigate air pollution

Scienmag

The curved barriers deflect pollution away from pedestrians and back onto the road Credit: n/a A unique curved barrier has been designed by researchers at Imperial College London, who publish new findings in the peer-reviewed journal Cities & Health on how the structure can protect people from the damaging effects of air pollution. With air […].

article thumbnail

Quench Bio Winds Down Operations Following ‘Successful Failure’

BioSpace

A little more than a year after securing $50 million in a Series A financing round, Quench Bio, an Atlas Venture company, is shutting down operations after failing to meet its therapeutic goals.

98
article thumbnail

First AI system for contactless monitoring of heart rhythm using smart speakers

Scienmag

Credit: Mark Stone/University of Washington Smart speakers, such as Amazon Echo and Google Home, have proven adept at monitoring certain health care issues at home. For example, researchers at the University of Washington have shown that these devices can detect cardiac arrests or monitor babies breathing. But what about tracking something even smaller: the minute […].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

GSK CEO Takes Financial Hit After Company Fails to Meet Internal Goal

BioSpace

GlaxoSmithKline failed to hit a key internal profit goal in 2020, due in large part to the impact of the COVID-19 pandemic. As a result, Chief Executive Officer Emma Walmsley took a nearly $2 million hit to her annual compensation.

98
article thumbnail

NYU Abu Dhabi study predicts motion sickness severity

Scienmag

Researchers discover a sensory sensitivity-based predictor of motion sickness, which can be used to personalize Virtual Reality technology and reduce discomfort Credit: NYU Abu Dhabi “It was clear that the greater an individual’s sensitivity to motion parallax cues, the more severe the motion sickness symptoms,” says lead NYU Abu Dhabi researcher Fast facts: The visual […].

article thumbnail

Jennifer Doudna’s Second Act: COVID-19 and Beyond

BioSpace

Doudna, the subject of a new book by Walter Isaacson titled “The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race,” has kept busy.

article thumbnail

The need for speed: Faster vaccine rollout critical to stronger recovery, says OECD

BioPharma Reporter

A global economic recovery is in sight but a faster and more effective vaccination rollout across the world is critical, while respecting necessary health and social distancing measures, according to the OECDâs latest Interim Economic Outlook.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

SMC accepts Zolgensma and Rozlytrek for use by NHS Scotland

Pharma Times

Both medicines reviewed through the SMC's PACE process

Medicine 123
article thumbnail

New lung cancer screening recommendation expands access but may not address inequities

Scienmag

Credit: UNC Lineberger Comprehensive Cancer Center CHAPEL HILL, NC — Calling the U.S. Preventive Services Task Force’s newly released recommendation statement to expand eligibility for annual lung cancer screening with low-dose computed tomography a step forward, UNC Lineberger Comprehensive Cancer Center researchers say future changes should address equity and implementation issues.

article thumbnail

2020 Tailwinds Usher in a Post-Pandemic Biotech Revolution

BioSpace

Cooperation and collaboration accelerated drug development timelines during the pandemic, and those gains are expected to continue into the coming years. Innovation is increasing too, as new tools are developed.

article thumbnail

‘Wearable microgrid’ uses the human body to sustainably power small gadgets

Scienmag

Credit: UC San Diego Jacobs School of Engineering Nanoengineers at the University of California San Diego have developed a “wearable microgrid” that harvests and stores energy from the human body to power small electronics. It consists of three main parts: sweat-powered biofuel cells, motion-powered devices called triboelectric generators, and energy-storing supercapacitors.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Promoting Diversity & Inclusion Through an Ethos of Cultural and Emotional Intelligence

BioSpace

Despite a historic push for greater diversity and inclusion (D&I), a significant disconnect prevails between good intentions and actual lived experiences.

84
article thumbnail

Nestlé Acquires Functional Beverage Brand Essentia Water After Selling Bottled Water Portfolio

XTalks

Nestlé has finalized the acquisition of premium beverage brand Essentia, the leading alkaline water brand and number one selling bottled water in the natural channel, for an undisclosed amount. The transaction follows Nestlé’s recent sale of its North American water business — including Poland Spring, Pure Life, Deer Park and other brands — to two private equity firms for $4.3 billion.

article thumbnail

Researchers grow most lifelike bone yet from woven cells

Scienmag

First organoid for bone will greatly increase understanding of bone formation and bone diseases Imagine using stem cells from your bone marrow to grow a piece of bone tissue in the lab, after which medical doctors explore which drugs have the desired effect on your bones. In this way, a tailor-made treatment plan would be […].

Doctors 73
article thumbnail

Copado lands $96m in Series B funding to fuel life-sciences digital transformation

Outsourcing Pharma

The development technology firm plans to use the funds, sourced from a wide range of investors, to expand its dev-ops platform and expand its global reach.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Charcot-Marie Tooth disease: A 100% French RNA-based therapeutic innovation

Scienmag

Charcot-Marie Tooth disease is the most common hereditary neurological disease in the world. It affects the peripheral nerves and causes progressive paralysis of the legs and hands. No treatment is currently available to fight this disease, which is due to the overexpression of a specific protein. Scientists from the CNRS, INSERM, the AP-HP and the […].

RNA 73
article thumbnail

Analyses Show bluebird's LentiGlobin Unlikely Cause of Leukemia in Trial Patient

BioSpace

Preliminary findings suggested that the BB305 LVV vector was present in the AML blast cells, but there was not sufficient information to determine causality.

Trials 75
article thumbnail

Gigantic jet spied from black hole in early universe

Scienmag

Credit: X-ray: NASA/CXO/JPL/T. Connor; Optical: Gemini/NOIRLab/NSF/AURA; Infrared: W.M. Keck Observatory; Illustration: NASA/CXC/M.Weiss Astronomers have discovered evidence for an extraordinarily long jet of particles coming from a supermassive black hole in the early universe, using NASA’s Chandra X-ray Observatory. If confirmed, it would be the most distant supermassive black hole with a jet detected in X-rays. […].

63
article thumbnail

Are SPACs Better Than Traditional IPOs?

BioSpace

Here’s the scoop on IPO versus SPAC (Special Purpose Acquisition Corporation) from Paul Mieyal, life sciences investment guru.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.